These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)]. Spasova K, Vŭlcheva B. Akush Ginekol (Sofiia); 1986 Jun; 25(3):84-90. PubMed ID: 3019168 [No Abstract] [Full Text] [Related]
5. [Errors in the prevention of Rh incompatibility]. Dmoch E. Acta Haematol Pol; 1988 Jun; 19(1-2):59-61. PubMed ID: 3149111 [No Abstract] [Full Text] [Related]
12. [Anti-D-prevention within the scope of a regional work-community]. Luboldt W, Lohmeyer H, Schmolling E, Hoize J, Neumann H. Med Klin; 1970 May 29; 65(22):1082-8. PubMed ID: 5000118 [No Abstract] [Full Text] [Related]
13. Plasmapheresis in Rh immunized pregnant women. Simonovits I, Vedrödi K, Jókuti I, Forgács J, Gy S. Acta Haematol Pol; 1981 May 29; 12(2):65-7. PubMed ID: 6795880 [No Abstract] [Full Text] [Related]
18. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage]. Mattone PG, Meriggi E, De Martin G. Minerva Ginecol; 1972 May 29; 24(7):337-41. PubMed ID: 4211573 [No Abstract] [Full Text] [Related]